Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Ascendis must wait 3 more months for FDA verdict on TransCon PTH
It’s been a long wait for Ascendis to score FDA approval for its hormone replacement therapy TransCon PTH. And now, it’ll take another three months.
Kevin Dunleavy
May 14, 2024 5:36pm
Bayer de-emphasizes the impact of Roche's Vabysmo on Eylea sales
May 14, 2024 11:46am
Sponsored
How Pharma Can Harness Education to Transform the Health Journey
May 13, 2024 8:00am
Novo bolsters star power of obesity blockbuster Wegovy
May 14, 2024 11:40am
Sponsored
Understanding how to energize, extend and capitalize the lifespan of mature drugs
May 13, 2024 8:00am
New name takes top spot in US patient group reputation ranking
May 14, 2024 10:54am